Search

Your search keyword '"Höftberger, Romana"' showing total 879 results
Start Over Author "Höftberger, Romana"
879 results on '"Höftberger, Romana"'

2. Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy

Author

Gelpi, Ellen, Reinecke, Raphael, Gaig, Carles, Iranzo, Alex, Sabater, Lidia, Molina-Porcel, Laura, Aldecoa, Iban, Endmayr, Verena, Högl, Birgit, Schmutzhard, Erich, Poewe, Werner, Pfausler, Bettina, Popovic, Mara, Pretnar-Oblak, Janja, Leypoldt, Frank, Matschke, Jakob, Glatzel, Markus, Erro, Elena Maria, Jerico, Ivonne, Caballero, Maria Cristina, Zelaya, Maria Victoria, Mariotto, Sara, Heidbreder, Anna, Kalev, Ognian, Weis, Serge, Macher, Stefan, Berger-Sieczkowski, Evelyn, Ferrari, Julia, Reisinger, Christoph, Klupp, Nikolaus, Tienari, Pentti, Rautila, Osma, Niemelä, Marja, Yilmazer-Hanke, Deniz, Guasp, Mar, Bloem, Bas, Van Gaalen, Judith, Kusters, Benno, Titulaer, Maarten, Fransen, Nina L., Santamaria, Joan, Dawson, Thimoty, Holton, Janice L., Ling, Helen, Revesz, Tamas, Myllykangas, Liisa, Budka, Herbert, Kovacs, Gabor G., Lewerenz, Jan, Dalmau, Josep, Graus, Francesc, Koneczny, Inga, and Höftberger, Romana

Published
2024
Full Text
View/download PDF

3. Single-nucleus RNA sequencing reveals glial cell type-specific responses to ischemic stroke in male rodents

Author

Bormann, Daniel, Knoflach, Michael, Poreba, Emilia, Riedl, Christian J., Testa, Giulia, Orset, Cyrille, Levilly, Anthony, Cottereau, Andréa, Jauk, Philipp, Hametner, Simon, Stranzl, Nadine, Golabi, Bahar, Copic, Dragan, Klas, Katharina, Direder, Martin, Kühtreiber, Hannes, Salek, Melanie, zur Nedden, Stephanie, Baier-Bitterlich, Gabriele, Kiechl, Stefan, Haider, Carmen, Endmayr, Verena, Höftberger, Romana, Ankersmit, Hendrik J., and Mildner, Michael

Published
2024
Full Text
View/download PDF

4. Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment

Author

Lu, I-Na, Cheung, Phyllis Fung-Yi, Heming, Michael, Thomas, Christian, Giglio, Giovanni, Leo, Markus, Erdemir, Merve, Wirth, Timo, König, Simone, Dambietz, Christine A., Schroeter, Christina B., Nelke, Christopher, Siveke, Jens T., Ruck, Tobias, Klotz, Luisa, Haider, Carmen, Höftberger, Romana, Kleinschnitz, Christoph, Wiendl, Heinz, Hagenacker, Tim, and Meyer zu Horste, Gerd

Published
2024
Full Text
View/download PDF

5. New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis

Author

Guo, Yong, Endmayr, Verena, Zekeridou, Anastasia, McKeon, Andrew, Leypoldt, Frank, Hess, Katharina, Kalinowska-Lyszczarz, Alicja, Klang, Andrea, Pakozdy, Akos, Höftberger, Elisabeth, Hametner, Simon, Haider, Carmen, De Simoni, Désirée, Peters, Sönke, Gelpi, Ellen, Röcken, Christoph, Oberndorfer, Stefan, Lassmann, Hans, Lucchinetti, Claudia F., and Höftberger, Romana

Published
2024
Full Text
View/download PDF

7. Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease

Author

Berger-Sieczkowski, Evelyn, Endmayr, Verena, Haider, Carmen, Ricken, Gerda, Jauk, Philipp, Macher, Stefan, Pirker, Walter, Högl, Birgit, Heidbreder, Anna, Schnider, Peter, Bradley-Zechmeister, Eszter, Mariotto, Sara, Koneczny, Inga, Reinecke, Raphael, Kasprian, Gregor, Weber, Corinna, Bergmann, Melanie, Milenkovic, Ivan, Berger, Thomas, Gaig, Carles, Sabater, Lidia, Graus, Francesc, Gelpi, Ellen, and Höftberger, Romana

Published
2023
Full Text
View/download PDF

8. ARID1B controls transcriptional programs of axon projection in an organoid model of the human corpus callosum

Author

Martins-Costa, Catarina, Wiegers, Andrea, Pham, Vincent A., Sidhaye, Jaydeep, Doleschall, Balint, Novatchkova, Maria, Lendl, Thomas, Piber, Marielle, Peer, Angela, Möseneder, Paul, Stuempflen, Marlene, Chow, Siu Yu A., Seidl, Rainer, Prayer, Daniela, Höftberger, Romana, Kasprian, Gregor, Ikeuchi, Yoshiho, Corsini, Nina S., and Knoblich, Jürgen A.

Published
2024
Full Text
View/download PDF

9. Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis

Author

Lang, Alexandra, Jeron, Raphael L., Lontzek, Bastian, Kiesel, Barbara, Mischkulnig, Mario, Berghoff, Anna S., Ricken, Gerda, Wöhrer, Adelheid, Rössler, Karl, Lötsch-Gojo, Daniela, Roetzer-Pejrimovsky, Thomas, Berger, Walter, Hainfellner, Johannes A., Höftberger, Romana, Widhalm, Georg, and Erhart, Friedrich

Published
2023
Full Text
View/download PDF

16. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease

Author

Gelpi, Ellen, Baiardi, Simone, Nos, Carlos, Dellavalle, Sofia, Aldecoa, Iban, Ruiz-Garcia, Raquel, Ispierto, Lourdes, Escudero, Domingo, Casado, Virgina, Barranco, Elena, Boltes, Anuncia, Molina-Porcel, Laura, Bargalló, Nuria, Rossi, Marcello, Mammana, Angela, Tiple, Dorina, Vaianella, Luana, Stoegmann, Elisabeth, Simonitsch-Klupp, Ingrid, Kasprian, Gregor, Klotz, Sigrid, Höftberger, Romana, Budka, Herbert, Kovacs, Gabor G., Ferrer, Isidre, Capellari, Sabina, Sanchez-Valle, Raquel, and Parchi, Piero

Published
2022
Full Text
View/download PDF

19. Antibody-Mediated Nodo- and Paranodopathies.

Author

Quinot, Valérie, Rostasy, Kevin, and Höftberger, Romana

Subjects
CELL adhesion molecules, CHILD patients, ADULTS, EPITOPES, PATHOLOGICAL physiology
Abstract

The recent discovery of pathogenic antibodies targeting cell adhesion molecules of the node of Ranvier has prompted efforts to develop a new classification for a subset of antibody-mediated peripheral neuropathies. These autoimmune nodo- and paranodopathies encompass epitopes such as neurofascin 155, neurofascin 186, contactin-1, and contactin-associated protein 1, with a high likelihood of involving additional yet unidentified proteins. So far, the investigation of this subset of patients was primarily focused on adults, with only rare reports of pediatric cases. Low awareness among pediatricians and insufficient availability of appropriate diagnostic methods in many laboratories may mask a higher pediatric incidence than currently observed. Diagnosis is made by transfected cell-based assays and ELISA to characterize the specific target antigen and antibody subclass that provides insight into the pathophysiology. Clinical features often resemble those of CIDP or GBS in adults, whilst in pediatric patients, although rare, an atypical CIDP phenotype has predominantly been reported. Yet, in contrast to classical immune-mediated neuropathies, the clinical course is usually rapidly progressive, and response to classical first-line therapy often poor. Although electrophysiological signs of demyelination are observed, segmental demyelination and inflammation are not present on pathological examination. Rather, few neuropathological reports demonstrate features of axonal neuropathy without signs of true de- or remyelination. This review aims to summarize recent findings on such nodo- and paranodoneuropathies, shining light on features of these disorders in pediatric patients, a still little-explored field with only a few reports currently present. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

20. The relation between BTK expression and iron accumulation of myeloid cells in multiple sclerosis.

Author

Steinmaurer, Anja, Riedl, Christian, König, Theresa, Testa, Giulia, Köck, Ulrike, Bauer, Jan, Lassmann, Hans, Höftberger, Romana, Berger, Thomas, Wimmer, Isabella, and Hametner, Simon

Subjects
BRUTON tyrosine kinase, MYELOID cells, IRON proteins, B cells, CHEMOKINE receptors, PROTEIN expression
Abstract

Activation of Bruton's tyrosine kinase (BTK) has been shown to play a crucial role in the proinflammatory response of B cells and myeloid cells upon engagement with B cell, Fc, Toll‐like receptor, and distinct chemokine receptors. Previous reports suggest BTK actively contributes to the pathogenesis of multiple sclerosis (MS). The BTK inhibitor Evobrutinib has been shown to reduce the numbers of gadolinium‐enhancing lesions and relapses in relapsing–remitting MS patients. In vitro, BTK inhibition resulted in reduced phagocytic activity and modulated BTK‐dependent inflammatory signaling of microglia and macrophages. Here, we investigated the protein expression of BTK and CD68 as well as iron accumulation in postmortem control (n = 10) and MS (n = 23) brain tissue, focusing on microglia and macrophages. MS cases encompassed active, chronic active, and inactive lesions. BTK+ and iron+ cells positively correlated across all regions of interests and, along with CD68, revealed highest numbers in the center of active and at the rim of chronic active lesions. We then studied the effect of BTK inhibition in the human immortalized microglia‐like HMC3 cell line in vitro. In particular, we loaded HMC3 cells with iron‐dextran and subsequently administered the BTK inhibitor Evobrutinib. Iron treatment alone induced a proinflammatory phenotype and increased the expression of iron importers as well as the intracellular iron storage protein ferritin light chain (FTL). BTK inhibition of iron‐laden cells dampened the expression of microglia‐related inflammatory genes as well as iron‐importers, whereas the iron‐exporter ferroportin was upregulated. Our data suggest that BTK inhibition not only dampens the proinflammatory response but also reduces iron import and storage in activated microglia and macrophages with possible implications on microglial iron accumulation in chronic active lesions in MS. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?

Author

Schachenhofer, Julia, primary, Gruber, Victoria‐Elisabeth, additional, Fehrer, Stefanie Valerie, additional, Haider, Carmen, additional, Glatter, Sarah, additional, Liszewska, Ewa, additional, Höftberger, Romana, additional, Aronica, Eleonora, additional, Rössler, Karl, additional, Jaworski, Jacek, additional, Scholl, Theresa, additional, and Feucht, Martha, additional

Published
2024
Full Text
View/download PDF

22. HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease

Author

Yogeshwar, Selina M, primary, Muñiz-Castrillo, Sergio, additional, Sabater, Lidia, additional, Peris-Sempere, Vicente, additional, Mallajosyula, Vamsee, additional, Luo, Guo, additional, Yan, Han, additional, Yu, Eric, additional, Zhang, Jing, additional, Lin, Ling, additional, Fagundes Bueno, Flavia, additional, Ji, Xuhuai, additional, Picard, Géraldine, additional, Rogemond, Véronique, additional, Pinto, Anne Laurie, additional, Heidbreder, Anna, additional, Höftberger, Romana, additional, Graus, Francesc, additional, Dalmau, Josep, additional, Santamaria, Joan, additional, Iranzo, Alex, additional, Schreiner, Bettina, additional, Giannoccaro, Maria Pia, additional, Liguori, Rocco, additional, Shimohata, Takayoshi, additional, Kimura, Akio, additional, Ono, Yoya, additional, Binks, Sophie, additional, Mariotto, Sara, additional, Dinoto, Alessandro, additional, Bonello, Michael, additional, Hartmann, Christian J, additional, Tambasco, Nicola, additional, Nigro, Pasquale, additional, Prüss, Harald, additional, McKeon, Andrew, additional, Davis, Mark M, additional, Irani, Sarosh R, additional, Honnorat, Jérôme, additional, Gaig, Carles, additional, Finke, Carsten, additional, and Mignot, Emmanuel, additional

Published
2024
Full Text
View/download PDF

26. Rituximab treatment in pediatric-onset multiple sclerosis

Author

Breu, Markus, Sandesjö, Fredrik, Milos, Ruxandra-Iulia, Svoboda, Jan, Salzer, Jonatan, Schneider, Lisa, Reichelt, Julian Benedikt, Bertolini, Annikki, Blaschek, Astrid, Fink, Katharina, Höftberger, Romana, Lycke, Jan, Rostásy, Kevin, Seidl, Rainer, Siegert, Sandy, Wickström, Ronny, Kornek, Barbara, Breu, Markus, Sandesjö, Fredrik, Milos, Ruxandra-Iulia, Svoboda, Jan, Salzer, Jonatan, Schneider, Lisa, Reichelt, Julian Benedikt, Bertolini, Annikki, Blaschek, Astrid, Fink, Katharina, Höftberger, Romana, Lycke, Jan, Rostásy, Kevin, Seidl, Rainer, Siegert, Sandy, Wickström, Ronny, and Kornek, Barbara

Abstract

Background and purpose: Rituximab (RTX) is frequently used off-label in multiple sclerosis. However, studies on the risk–benefit profile of RTX in pediatric-onset multiple sclerosis are scarce. Methods: In this multicenter retrospective cohort study, patients with pediatric-onset multiple sclerosis from Sweden, Austria and Germany, who received RTX treatment were identified by chart review. Annualized relapse rates, Expanded Disability Status Scale scores and magnetic resonance imaging parameters (new T2 lesions and contrast-enhancing lesions) were assessed before and during RTX treatment. The proportion of patients who remained free from clinical and disease activity (NEDA-3) during RTX treatment was calculated. Side effects such as infusion-related reactions, infections and laboratory abnormalities were assessed. Results: Sixty-one patients received RTX during a median (interquartile range) follow-up period of 20.9 (35.6) months. The annualized relapse rate decreased from 0.6 (95% confidence interval [CI] 0.38–0.92) to 0.03 (95% CI 0.02–0.14). The annual rate of new T2 lesions decreased from 1.25 (95% CI 0.70–2.48) to 0.08 (95% CI 0.03–0.25) and annual rates of new contrast-enhancing lesions decreased from 0.86 (95% CI 0.30–3.96) to 0. Overall, 70% of patients displayed no evidence of disease activity (NEDA-3). Adverse events were observed in 67% of patients. Six patients discontinued treatment due to ongoing disease activity or adverse events. Conclusion: Our study provides class IV evidence that RTX reduces clinical and radiological activity in pediatric-onset multiple sclerosis.

Published
2024
Full Text
View/download PDF

31. Rituximab treatment in pediatric‐onset multiple sclerosis

Author

Breu, Markus, primary, Sandesjö, Fredrik, additional, Milos, Ruxandra‐Iulia, additional, Svoboda, Jan, additional, Salzer, Jonatan, additional, Schneider, Lisa, additional, Reichelt, Julian Benedikt, additional, Bertolini, Annikki, additional, Blaschek, Astrid, additional, Fink, Katharina, additional, Höftberger, Romana, additional, Lycke, Jan, additional, Rostásy, Kevin, additional, Seidl, Rainer, additional, Siegert, Sandy, additional, Wickström, Ronny, additional, and Kornek, Barbara, additional

Published
2024
Full Text
View/download PDF

33. A clinical approach to diagnosis of autoimmune encephalitis

Author

Graus, Francesc, Titulaer, Maarten J, Balu, Ramani, Benseler, Susanne, Bien, Christian G, Cellucci, Tania, Cortese, Irene, Dale, Russell C, Gelfand, Jeffrey M, Geschwind, Michael, Glaser, Carol A, Honnorat, Jerome, Höftberger, Romana, Iizuka, Takahiro, Irani, Sarosh R, Lancaster, Eric, Leypoldt, Frank, Prüss, Harald, Rae-Grant, Alexander, Reindl, Markus, Rosenfeld, Myrna R, Rostásy, Kevin, Saiz, Albert, Venkatesan, Arun, Vincent, Angela, Wandinger, Klaus-Peter, Waters, Patrick, and Dalmau, Josep

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Immunization, Prevention, Clinical Research, Autoimmune Disease, Brain Disorders, Vaccine Related, Neurosciences, Neurodegenerative, 4.1 Discovery and preclinical testing of markers and technologies, 4.2 Evaluation of markers and technologies, Detection, screening and diagnosis, Metabolic and endocrine, Inflammatory and immune system, Autoimmune Diseases of the Nervous System, Encephalitis, Humans, Neurology & Neurosurgery, Clinical sciences
Abstract

Encephalitis is a severe inflammatory disorder of the brain with many possible causes and a complex differential diagnosis. Advances in autoimmune encephalitis research in the past 10 years have led to the identification of new syndromes and biomarkers that have transformed the diagnostic approach to these disorders. However, existing criteria for autoimmune encephalitis are too reliant on antibody testing and response to immunotherapy, which might delay the diagnosis. We reviewed the literature and gathered the experience of a team of experts with the aims of developing a practical, syndrome-based diagnostic approach to autoimmune encephalitis and providing guidelines to navigate through the differential diagnosis. Because autoantibody test results and response to therapy are not available at disease onset, we based the initial diagnostic approach on neurological assessment and conventional tests that are accessible to most clinicians. Through logical differential diagnosis, levels of evidence for autoimmune encephalitis (possible, probable, or definite) are achieved, which can lead to prompt immunotherapy.

Published
2016

36. Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome

Author

Bien, Christian G., Bien, Corinna I., Dogan Onugoren, Müjgan, De Simoni, Desiree, Eigler, Verena, Haensch, Carl-Albrecht, Holtkamp, Martin, Ismail, Fatme S., Kurthen, Martin, Melzer, Nico, Mayer, Kristina, von Podewils, Felix, Rauschka, Helmut, Rossetti, Andrea O., Schäbitz, Wolf-Rüdiger, Simova, Olga, Witt, Karsten, Höftberger, Romana, and May, Theodor W.

Published
2020
Full Text
View/download PDF

38. Encephalitis and AMPA receptor antibodies

Author

Höftberger, Romana, van Sonderen, Agnes, Leypoldt, Frank, Houghton, David, Geschwind, Michael, Gelfand, Jeffrey, Paredes, Mercedes, Sabater, Lidia, Saiz, Albert, Titulaer, Maarten J, Graus, Francesc, and Dalmau, Josep

Subjects
Immunization, Rare Diseases, Neurosciences, Biotechnology, Cancer, Clinical Research, Brain Disorders, Lung, Aetiology, 2.1 Biological and endogenous factors, Adult, Aged, Aged, 80 and over, Autoantibodies, Brain, Comorbidity, Encephalitis, Female, Follow-Up Studies, HEK293 Cells, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Receptors, AMPA, Retrospective Studies, Young Adult, Clinical Sciences, Cognitive Sciences, Neurology & Neurosurgery
Abstract

ObjectiveWe report the clinical features, comorbidities, and outcome of 22 newly identified patients with antibodies to the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR).MethodsThis was a retrospective review of patients diagnosed between May 2009 and March 2014. Immunologic techniques have been reported previously.ResultsPatients' median age was 62 years (range 23-81; 14 female). Four syndromes were identified: 12 (55%) patients presented with distinctive limbic encephalitis (LE), 8 (36%) with limbic dysfunction along with multifocal/diffuse encephalopathy, one with LE preceded by motor deficits, and one with psychosis with bipolar features. Fourteen patients (64%) had a tumor demonstrated pathologically (5 lung, 4 thymoma, 2 breast, 2 ovarian teratoma) or radiologically (1 lung). Additional antibodies occurred in 7 patients (3 onconeuronal, 1 tumor-related, 2 cell surface, and 1 tumor-related and cell surface), all with neurologic symptoms or tumor reflecting the concurrent autoimmunity. Treatment and outcome were available from 21 patients (median follow-up 72 weeks, range 5-266): 5 had good response to immunotherapy and tumor therapy, 10 partial response, and 6 did not improve. Eventually 5 patients died; all had a tumor or additional paraneoplastic symptoms related to onconeuronal antibodies. Coexistence of onconeuronal antibodies predicted a poor outcome (p = 0.009).ConclusionAnti-AMPAR encephalitis usually manifests as LE, can present with other symptoms or psychosis, and is paraneoplastic in 64% of cases. Complete and impressive neurologic improvement can occur, but most patients have partial recovery. Screening for a tumor and onconeuronal antibodies is important because their detection influences outcome.

Published
2015

40. Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy

Author

Martín-Aguilar, Lorena, Lleixà, Cinta, Pascual-Goñi, Elba, Caballero-Ávila, Marta, Martínez-Martínez, Laura, Díaz-Manera, Jordi, Rojas-García, Ricard, Cortés-Vicente, Elena, Turon-Sans, Janina, de Luna, Noemi, Suárez-Calvet, Xavier, Gallardo, Eduard, Rajabally, Yusuf, Scotton, Sangeeta, Jacobs, Bart C., Baars, Adája, Cortese, Andrea, Vegezzi, Elisa, Höftberger, Romana, Zimprich, Fritz, Roesler, Cornelia, Nobile-Orazio, Eduardo, Liberatore, Giuseppe, Hiew, Fu Liong, Martínez-Piñeiro, Alicia, Carvajal, Alejandra, Piñar-Morales, Raquel, Usón-Martín, Mercedes, Albertí, Olalla, López-Pérez, Maria Ángeles, Márquez, Fabian, Pardo-Fernández, Julio, Muñoz-Delgado, Laura, Cabrera-Serrano, Macarena, Ortiz, Nicolau, Bartolomé, Manuel, Duman, Özgür, Bril, Vera, Segura-Chávez, Darwin, Pitarokoili, Kalliopi, Steen, Claudia, Illa, Isabel, and Querol, Luis

Published
2022
Full Text
View/download PDF

41. Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases

Author

Schanda, Kathrin, Peschl, Patrick, Lerch, Magdalena, Seebacher, Barbara, Mindorf, Swantje, Ritter, Nora, Probst, Monika, Hegen, Harald, Di Pauli, Franziska, Wendel, Eva-Maria, Lechner, Christian, Baumann, Matthias, Mariotto, Sara, Ferrari, Sergio, Saiz, Albert, Farrell, Michael, Leite, Maria Isabel S., Irani, Sarosh R., Palace, Jacqueline, Lutterotti, Andreas, Kümpfel, Tania, Vukusic, Sandra, Marignier, Romain, Waters, Patrick, Rostasy, Kevin, Berger, Thomas, Probst, Christian, Höftberger, Romana, and Reindl, Markus

Published
2021
Full Text
View/download PDF

42. Brazilian autoimmune encephalitis network (BrAIN): antibody profile and clinical characteristics from a multicenter study

Author

de Freitas Dias, Bruna, primary, Fieni Toso, Fabio, additional, Slhessarenko Fraife Barreto, Maria Eduarda, additional, de Araújo Gleizer, René, additional, Dellavance, Alessandra, additional, Kowacs, Pedro André, additional, Teive, Helio, additional, Spitz, Mariana, additional, Freire Borges Juliano, Aline, additional, Januzi de Almeida Rocha, Letícia, additional, Braga-Neto, Pedro, additional, Ribeiro Nóbrega, Paulo, additional, Oliveira-Filho, Jamary, additional, Maciel Dias, Ronaldo, additional, de Oliveira Godeiro Júnior, Clécio, additional, Martins Maia, Fernanda, additional, Barbosa Thomaz, Rodrigo, additional, Santos, Mara Lúcia, additional, Sousa de Melo, Eduardo, additional, da Nóbrega Júnior, Adaucto Wanderley, additional, Lin, Katia, additional, Graziani Povoas Barsottini, Orlando, additional, Endmayr, Verena, additional, Coelho Andrade, Luís Eduardo, additional, Höftberger, Romana, additional, and Almeida Dutra, Lívia, additional

Published
2023
Full Text
View/download PDF

43. The influence of brain iron and myelin on magnetic susceptibility and effective transverse relaxation - A biochemical and histological validation study

Author

Hametner, Simon, Endmayr, Verena, Deistung, Andreas, Palmrich, Pilar, Prihoda, Max, Haimburger, Evelin, Menard, Christian, Feng, Xiang, Haider, Thomas, Leisser, Marianne, Köck, Ulrike, Kaider, Alexandra, Höftberger, Romana, Robinson, Simon, Reichenbach, Jürgen R., Lassmann, Hans, Traxler, Hannes, Trattnig, Siegfried, and Grabner, Günther

Published
2018
Full Text
View/download PDF

46. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients

Author

Jarius, Sven, Pellkofer, Hannah, Siebert, Nadja, Korporal-Kuhnke, Mirjam, Hümmert, Martin W., Ringelstein, Marius, Rommer, Paulus S., Ayzenberg, Ilya, Ruprecht, Klemens, Klotz, Luisa, Asgari, Nasrin, Zrzavy, Tobias, Höftberger, Romana, Tobia, Rafik, Buttmann, Mathias, Fechner, Kai, Schanda, Kathrin, Weber, Martin, Asseyer, Susanna, Haas, Jürgen, Lechner, Christian, Kleiter, Ingo, Aktas, Orhan, Trebst, Corinna, Rostasy, Kevin, Reindl, Markus, Kümpfel, Tania, Paul, Friedemann, and Wildemann, Brigitte

Published
2020
Full Text
View/download PDF

47. Correction to: Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome

Author

Bien, Christian G., Bien, Corinna I., Onugoren, Müjgan Dogan, De Simoni, Desiree, Eigler, Verena, Haensch, Carl-Albrecht, Holtkamp, Martin, Ismail, Fatme S., Kurthen, Martin, Melzer, Nico, Mayer, Kristina, von Podewils, Felix, Rauschka, Helmut, Rossetti, Andrea O., Schäbitz, Wolf-Rüdiger, Simova, Olga, Witt, Karsten, Höftberger, Romana, and May, Theodor W.

Published
2021
Full Text
View/download PDF

48. Imaging brain tissue architecture across millimeter to nanometer scales

Author

Michalska, Julia M., primary, Lyudchik, Julia, additional, Velicky, Philipp, additional, Štefaničková, Hana, additional, Watson, Jake F., additional, Cenameri, Alban, additional, Sommer, Christoph, additional, Amberg, Nicole, additional, Venturino, Alessandro, additional, Roessler, Karl, additional, Czech, Thomas, additional, Höftberger, Romana, additional, Siegert, Sandra, additional, Novarino, Gaia, additional, Jonas, Peter, additional, and Danzl, Johann G., additional

Published
2023
Full Text
View/download PDF

50. Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis

Author

Spatola, Marianna, Petit Pedrol, Mar, Maudes, Estibaliz, Simabukuro, Mateus, Muñiz-Castrillo, Sergio, Pinto, Anne-Laurie, Wandinger, Klaus-Peter, Spiegler, Juliane, Schramm, Peter, Dutra, Lívia Almeida, Iorio, Raffaele, Kornblum, Cornelia, Bien, Christian G., Höftberger, Romana, Leypoldt, Frank, Titulaer, Maarten J., Sillevis Smitt, Peter, Honnorat, Jérôme, Rosenfeld, Myrna R., Graus, Francesc, and Dalmau, Josep

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results